SubsidieMeestersMobile Bio-Lab to support first response in Arbovirus outbreaks
MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.
Projectdetails
Introduction
The WHO estimates that vector-borne diseases (VBD) account for more than 17% of all infectious diseases. Every year, more than 2.5 billion people are at risk of contracting dengue alone, and VBDs cause almost 1 million deaths.
Background
In the last decades, several species of invasive disease-carrying mosquitoes have invaded the northern hemisphere of the planet through the transport of goods, increasing international travel, and climate change. In 2018, a West Nile fever outbreak transmitted by mosquitoes occurred in the EU. For this disease, there are no vaccines or medications. There were 1503 cases reported in 11 countries, and 181 deaths.
Need for VBD Mobile Bio-Labs
VBD Mobile Bio-Labs could have assisted health authorities in containing this outbreak, reducing cases and preventing deaths. Unfortunately, such a system does not exist.
Project Overview: MOBVEC
MOBVEC will be the first VBD Mobile Bio-Lab, providing:
- Automatic information about vector populations, obtained in real-time by smart traps, powered by machine learning and edge computing: insect species, sex, age, and viral infection.
- GEOSS compliant vector risk maps of adult insects and eggs/larvae, built on field and Copernicus data.
- GEOSS compliant disease transmission models in mosquito populations, fusing data from Copernicus, clinical and diagnostic data of reference labs, and vector risk maps.
- GEOSS compliant citizen-science platform to reinforce the surveillance of mosquitoes using citizens as observation nodes.
- VBD mobile bio-lab with the capacities of points 1, 2, 3, and 4 + VBD epidemiological maps and forecast models, to be rapidly operational in the heart of outbreaks to assist first responders.
Impact
This technology will be the first line of defense against disease vectors worldwide, help prevent and fight devastating disease outbreaks, and will save lives while saving millions of euros in healthcare and lost working hours. This has never been done before, and our consortium has the interdisciplinary research capacities to make it a reality.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.998.500 |
| Totale projectbegroting | € 2.998.500 |
Tijdlijn
| Startdatum | 1-7-2023 |
| Einddatum | 30-6-2027 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- IRIDEON SLpenvoerder
- AVIA-GIS NV
- UNIVERSITE CATHOLIQUE DE LOUVAIN
- INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- NAZKA MAPPS BVBA
- Agencia de Salut Publica de Barcelona
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
ECL-based Infectious Pathogen (bio)SEnsorECLIPSE aims to develop a portable, cost-effective platform using ultrasensitive detection methods for rapid identification of infectious pathogens, enhancing response to future pandemics. | EIC Pathfinder | € 2.683.996 | 2022 | Details |
FLow detection of virUses by graphene Field Effect Transistor microarraysFLUFET aims to develop an automated sensor using graphene technology for continuous detection of zoonotic viruses, enhancing pandemic prevention through real-time monitoring of animal farms. | EIC Pathfinder | € 3.200.092 | 2024 | Details |
ECL-based Infectious Pathogen (bio)SEnsor
ECLIPSE aims to develop a portable, cost-effective platform using ultrasensitive detection methods for rapid identification of infectious pathogens, enhancing response to future pandemics.
FLow detection of virUses by graphene Field Effect Transistor microarrays
FLUFET aims to develop an automated sensor using graphene technology for continuous detection of zoonotic viruses, enhancing pandemic prevention through real-time monitoring of animal farms.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Ontwikkeling on site diagnostische tools, vaccins en virale remmers ter bestrijding van het westnijlvirus bij mens en dierDit project richt zich op de ontwikkeling van snelle diagnostische testen en vaccins tegen het Westnijlvirus om infecties bij mens en dier te diagnosticeren, voorkomen en behandelen. | Mkb-innovati... | € 90.146 | 2022 | Details |
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoesThis project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies. | ERC Starting... | € 1.500.000 | 2023 | Details |
THERAPRODit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen. | Mkb-innovati... | € 163.275 | 2019 | Details |
Ontwikkeling testen en vaccins ter bestrijding van Lyme en babesiose bij mens en dierHet project ontwikkelt snelle diagnostische testen en mozaïekvaccins tegen Lyme- en babesia-infecties om de toenemende tekenproblematiek bij mens en dier te bestrijden, met een focus op One Health. | Mkb-innovati... | € 116.613 | 2021 | Details |
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease EcologyThis project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control. | ERC Starting... | € 1.500.000 | 2025 | Details |
Ontwikkeling on site diagnostische tools, vaccins en virale remmers ter bestrijding van het westnijlvirus bij mens en dier
Dit project richt zich op de ontwikkeling van snelle diagnostische testen en vaccins tegen het Westnijlvirus om infecties bij mens en dier te diagnosticeren, voorkomen en behandelen.
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes
This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.
THERAPRO
Dit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen.
Ontwikkeling testen en vaccins ter bestrijding van Lyme en babesiose bij mens en dier
Het project ontwikkelt snelle diagnostische testen en mozaïekvaccins tegen Lyme- en babesia-infecties om de toenemende tekenproblematiek bij mens en dier te bestrijden, met een focus op One Health.
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease Ecology
This project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control.